login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ACER THERAPEUTICS INC (ACER) Stock News
USA
- NASDAQ:ACER -
US00444P1084
-
Common Stock
0.9
USD
+0.03 (+3.41%)
Last: 11/8/2023, 8:19:05 PM
0.8005
USD
-0.1 (-11.06%)
After Hours:
11/8/2023, 8:19:05 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ACER Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
2 years ago - By: Acer Therapeutics Inc.
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
2 years ago - By: Kahn Swick & Foti, LLC
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER
2 years ago - By: Benzinga
- Mentions:
ZVRA
Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics
2 years ago - By: Kahn Swick & Foti, LLC
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER
2 years ago - By: Brodsky & Smith LLC
- Mentions:
NYSE
SOVO
CTG
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq -
2 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra
2 years ago - By: InvestorPlace
- Mentions:
SHOP
AMZN
PLTR
AXLA
Shopify (SHOP) Stock Jumps 6% on Amazon Deal
2 years ago - By: Halper Sadeh LLC
ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders
2 years ago - By: InvestorPlace
- Mentions:
AXLA
NCNC
ICCT
Why Is Axcella Health (AXLA) Stock Down 21% Today?
2 years ago - By: Brodsky & Smith LLC
- Mentions:
SOVO
CTG
DBTX
ZVRA
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq -
2 years ago - By: InvestorPlace
- Mentions:
ZVRA
NCNC
ICCT
Why Is Acer Therapeutics (ACER) Stock Up 85% Today?
2 years ago - By: InvestorPlace
- Mentions:
ICCT
NCNC
ALLR
SATX
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
2 years ago - By: Seeking Alpha
Acer Therapeutics will reacquire OLPRUVA rights from Relief Therapeutics (NASDAQ:ACER)
2 years ago - By: Acer Therapeutics Inc.
Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
2 years ago - By: Acer Therapeutics Inc.
Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Please enable JavaScript to continue using this application.